Recombinant human ABCD3 (ATP-binding cassette sub-family D member 3) is a transmembrane protein expressed in heterologous systems for research purposes. Key molecular attributes include:
| Property | Value |
|---|---|
| Gene Name | ABCD3 |
| Protein Name | ATP-binding cassette sub-family D member 3, PMP70, PXMP1 |
| UniProt ID | P28288 |
| Chromosomal Location | 1p21.3 |
| Protein Length | 659 amino acids |
| Molecular Weight | 75.5 kDa |
| Transmembrane Domains | Multi-pass membrane protein |
ABCD3 belongs to the ALD subfamily of ABC transporters and functions as a half-transporter, requiring dimerization with a partner protein (e.g., ABCD1/2) for full activity . It is critical for peroxisomal fatty acid β-oxidation, transporting long-chain and branched-chain fatty acyl-CoA esters .
Recombinant ABCD3 is produced using diverse systems to optimize yield and functionality:
Recent advancements include chimeric ABCD3 (chABCD3), combining the N-terminal segment of C. elegans PMP2 with human core domains to improve solubility and crystallization .
ABCD3 mutations cause severe metabolic disorders:
Zellweger Syndrome: Autosomal recessive peroxisome biogenesis disorder linked to impaired fatty acid import .
Bile Acid Synthesis Defects: Congenital deficiencies in bile acid production .
Low ABCD3 mRNA expression correlates with poor survival in colorectal cancer (CRC), suggesting its potential as a diagnostic/prognostic biomarker .
ATP-binding Cassette Sub-Family D Member 3 (ABCD3), also identified as PMP70, is a peroxisomal membrane protein that belongs to the ABC transporter family. It is characterized by the following molecular properties:
Molecular Weight: The observed molecular weight is approximately 70 kDa .
Gene Identification: ABCD3 is encoded by the gene with GeneID 5825 and is registered in multiple databases including UniProt (Primary AC: P28288), OMIM (170995), and NCBI (Accession: NP_002849.1, NM_002858) .
Protein Structure: ABCD3 contains six transmembrane helices (TMs) and exhibits a domain-swapped arrangement when assembled as a dimer .
Functional Role: ABCD3 is primarily responsible for the transport of long-chain fatty acid-CoA (LCFA-CoA) across the peroxisomal membrane, playing a crucial role in lipid metabolism and peroxisomal function .
The protein features structural elements that are essential for its transport function, including transmembrane domains (TMDs) that form substrate binding cavities and nucleotide-binding domains (NBDs) that hydrolyze ATP to power the transport process .
The ABCD subfamily consists of four members with distinct functional roles and localizations:
| ABCD Protein | Alternative Name | Cellular Localization | Primary Substrate Specificity |
|---|---|---|---|
| ABCD1 | ALDP | Peroxisomes | Very-long-chain fatty acids (VLCFAs) |
| ABCD2 | ALDRP | Peroxisomes | VLCFAs (different specificity from ABCD1) |
| ABCD3 | PMP70 | Peroxisomes | Long-chain fatty acid-CoA (LCFA-CoA) |
| ABCD4 | - | Lysosomes | Cobalamin (Vitamin B12) |
ABCD3 differs from its subfamily members in several important ways:
While ABCD1 and ABCD2 primarily transport very-long-chain fatty acids (VLCFAs) with different specificities, ABCD3 was reported to transport LCFA-CoA .
ABCD3 shares the peroxisomal localization with ABCD1 and ABCD2, unlike ABCD4 which is localized to lysosomes .
ABCD2 can compensate for the function loss of ABCD1 in certain conditions, suggesting some functional redundancy between these two proteins, whereas ABCD3 has more distinct substrate preferences .
These functional differences highlight the specialized role of ABCD3 in peroxisomal metabolism and underscore the importance of studying each ABCD transporter in its specific cellular context.
ABCD3 antibodies serve as valuable tools in multiple research applications, enabling scientists to study the expression, localization, and function of this important peroxisomal transporter. The most common applications include:
| Application | Recommended Dilution | Purpose in ABCD3 Research |
|---|---|---|
| ELISA | 1/20000 - 1/80000 | Quantitative detection of ABCD3 in biological samples |
| Western Blot (WB) | 1/500 - 1/2000 | Analysis of ABCD3 protein expression levels and molecular weight confirmation |
| Immunohistochemistry (IHC) | 1/100 - 1/200 | Visualization of ABCD3 localization in tissue sections |
When using these applications, researchers should note that optimal dilutions/concentrations should be determined experimentally by the end user, as factors such as sample type, detection method, and antibody lot can influence results . The polyclonal antibody described in the search results is generated in rabbits against a recombinant fragment corresponding to amino acids 318-586 of human ABCD3, making it highly specific for human ABCD3 with predicted cross-reactivity with mouse and rat ABCD3 .
The structural analysis of ABCD3 reveals several key features that determine its substrate specificity and transport mechanism:
These structural elements work in concert to enable ABCD3 to specifically recognize, bind, and transport LCFA-CoA across the peroxisomal membrane in an ATP-dependent manner.
ABCD3 undergoes significant conformational changes during its transport cycle, which are essential for substrate binding, translocation, and release:
Ligand-Free State: In the absence of substrate, ABCD3 adopts a cytosolic-facing conformation with specific spatial arrangements of its transmembrane helices .
Substrate-Bound State: Upon binding of substrates such as C22:0-CoA, conformational changes occur primarily in the transmembrane domains. The distance between TM4 and TM6 changes, reflecting alterations in the substrate binding cavity .
ATP-Bound State: Binding of ATP triggers further dramatic conformational changes that facilitate substrate translocation. These changes involve cooperative movements between the transmembrane domains and the nucleotide-binding domains .
The transport cycle involves the extrusion of unknown densities at the crevice of TMDs during substrate loading, as observed in structural studies . When comparing the ligand-free structure with C22:0-CoA-bound and ATP-bound structures, researchers have identified dramatic conformational changes that illustrate the mechanical basis of transport .
These structural transitions create an alternating access mechanism that allows ABCD3 to bind substrates on one side of the membrane, undergo conformational changes, and release substrates on the other side of the membrane, all powered by ATP hydrolysis.
Effective study of ABCD3 transport activity requires a combination of biochemical, structural, and functional approaches:
Purification and Reconstitution:
ATP Hydrolysis Assays:
Transport Assays with Radiolabeled or Fluorescent Substrates:
Structural Analysis:
Mutational Analysis:
By combining these approaches, researchers can gain comprehensive insights into ABCD3 transport activity and understand how structural features relate to functional properties.
When designing experiments using ABCD3 antibodies, researchers should consider several critical parameters to ensure optimal results:
For Western blot applications specifically, researchers should expect to observe ABCD3 at approximately 70 kDa, which corresponds to its observed molecular weight . When preparing samples for immunohistochemistry, optimization of fixation methods and antigen retrieval protocols may be necessary to expose ABCD3 epitopes effectively, particularly given its membrane localization in peroxisomes.
Analyzing and interpreting structural data for ABCD3 requires careful consideration of multiple approaches and potential discrepancies between experimental and predictive models:
Comparison Between Cryo-EM Structures and Predicted Models:
Conformational State Considerations:
Comparative Analysis with Related Transporters:
Comparison between ABCD3 and other ABC transporters, such as phosphatidylcholine transporter ABCB4, in three major states of a working cycle (ligand-free, substrate-bound, and ATP-bound states) provides context for interpreting ABCD3-specific structural features .
These comparisons can highlight conserved mechanisms versus unique aspects of ABCD3 function.
Resolution Considerations:
The nominal resolution of the cryo-EM structure at 3.4 Å provides high confidence for most regions, but some regions may have lower local resolution .
For instance, the C-terminal helix regions had a local resolution of approximately 4.0 Å, which was not accurate enough to build a complete atomic model .
Integration with Functional Data:
By carefully considering these factors, researchers can extract meaningful insights from structural data and develop accurate models of ABCD3 function that bridge structural information with physiological relevance.
Understanding the impact of mutations on ABCD3 function requires systematic classification and comprehensive functional analysis. Researchers can approach this using the following framework:
Structural Classification of Mutations:
Based on structural mapping, mutations can be classified into three main groups:
Group 1: Mutations affecting residues that line the substrate-binding cavity, likely influencing substrate coordination and delivery .
Group 2: Mutations located in other regions of the transmembrane domains (TMDs) that undergo conformational changes during the transport cycle .
Group 3: Mutations located on the nucleotide-binding domains (NBDs) that may influence ATP hydrolysis .
Functional Assessment Parameters:
To comprehensively evaluate the impact of mutations, researchers should assess:
| Assessment Parameter | Methodology | Significance |
|---|---|---|
| Cellular Localization | Fluorescence microscopy of tagged proteins | Determines if mutation affects proper targeting to peroxisomes |
| Protein Expression Level | Western blot with GAPDH as loading control | Quantifies impact on protein stability and expression |
| Thermostability | Thermal shift assays | Measures Tm values to assess structural integrity of mutant proteins |
| ATP Hydrolysis | ATPase assays | Quantifies ability to hydrolyze ATP, essential for transport function |
| Transport Activity | Transport of C22:0-CoA, C24:0-CoA, C26:0-CoA | Directly measures functional impact on substrate transport |
Correlation of Structure-Function Relationships:
Mutations in substrate binding regions often directly affect substrate specificity or transport efficiency .
Mutations in conformationally important regions may impact the transport cycle without affecting substrate binding .
Mutations in NBDs typically affect ATP hydrolysis rates but may also have allosteric effects on substrate binding .
Integration with Computational Predictions:
By applying this comprehensive analytical framework, researchers can gain detailed insights into how specific mutations impact ABCD3 structure and function, potentially leading to new therapeutic strategies for disorders associated with ABCD3 dysfunction.